- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
9
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
Natera
Market Cap: US$40.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$279.32
7D
2.6%
1Y
76.0%
AbbVie
Market Cap: US$461.3b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$261.07
7D
2.7%
1Y
39.1%
Travere Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$56.92
7D
-2.4%
1Y
289.7%
Sotera Health
Market Cap: US$5.1b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$17.93
7D
2.3%
1Y
57.3%
Mesa Laboratories
Market Cap: US$583.1m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$105.54
7D
6.0%
1Y
13.6%
BioLife Solutions
Market Cap: US$1.4b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$28.11
7D
-0.7%
1Y
28.9%
Waters
Market Cap: US$37.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$379.29
7D
2.8%
1Y
9.4%
SIGA Technologies
Market Cap: US$276.9m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$3.86
7D
6.9%
1Y
-42.6%
Repligen
Market Cap: US$8.0b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$142.40
7D
3.9%
1Y
14.4%